Extending Limits of Resection for Metastatic Colorectal Cancer: Risk Benefit Ratio

被引：23
|
作者：
Yang, Anthony D. [1 ]
Brouquet, Antoine [1 ]
Vauthey, Jean Nicolas [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2010年 / 102卷 / 08期
关键词：
colorectal cancer; liver metastases; resectability; chemotherapy; SYNCHRONOUS LIVER METASTASES; PORTAL-VEIN EMBOLIZATION; HEPATIC RESECTION; 2-STAGE HEPATECTOMY; 1ST-LINE TREATMENT; PERIOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; RADIOFREQUENCY ABLATION; MAJOR HEPATECTOMY; HANGING MANEUVER;
D O I：
10.1002/jso.21701
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Improvements in treatment strategies and a better knowledge of tumor biology have contributed to an increase in the number of patients with colorectal liver metastases (CLM) who are candidate for surgery. These progresses are on going and the introduction of effective systemic therapy agents contributes further to the increase in the resectability of patients with advanced CLM. J. Surg. Oncol. 2010; 102: 996-1001. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码：996 / 1001
页数：6
相关论文
共 50 条
12345